Trazodone
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Prescription serotonin antagonist and reuptake inhibitor (SARI) approved for major depressive disorder. Most commonly used off-label at low doses as a sleep aid due to its potent sedating and non-habit-forming properties. At higher antidepressant doses, provides serotonergic and anxiolytic activity. A widely used alternative to benzodiazepines and Z-drugs for insomnia. Dosage must be determined by your prescribing physician.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Prescription serotonin antagonist and reuptake inhibitor (SARI) approved for major depressive disorder. NutriStack rates the supporting evidence as moderate. Common adult dosing is 50–100 mg at bedtime for insomnia; 150–400 mg daily for depression (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete sodium. This profile indexes 11 sources.
The bottom line
Evidence rating moderate. Most-documented uses: insomnia improvement (off-label), depression symptom relief, anxiety reduction. 11 sources indexed (2003–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Inhibits serotonin reuptake (SERT blockade) while antagonizing serotonin 5-HT2A and 5-HT2C receptors. Also antagonizes histamine H1 receptors (contributing to sedation) and alpha-1 adrenergic receptors (contributing to orthostatic hypotension). The dual action of serotonin reuptake inhibition and 5-HT2A antagonism may enhance net serotonergic signaling through 5-HT1A receptors.
Dosing & protocol.
Take shortly after a meal or light snack to improve absorption and reduce dizziness. Take at bedtime due to sedating effects.9
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Sodium
ModerateAntidepressant-associated SIADH can increase renal free-water retention and dilute serum sodium, producing hyponatremia.
Full safety detail.
Side effects
- Sedation and drowsiness
- Dizziness
- Orthostatic hypotension
- Dry mouth
- Headache
- Nausea
- Priapism (rare but serious)
- Blurred vision
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
3- 1Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysisPMIDZheng Y, Lv T, Wu J et al. · Scientific reports · 2022
Zheng Y, Lv T, Wu J et al.. Trazodone changed the polysomnographic sleep architecture in insomnia disorder: a systematic review and meta-analysis. Scientific reports. 2022
- 2Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials.PMIDYi XY, Ni SF, Ghadami MR et al. · Sleep Medicine · 2018
Meta-analysis of RCTs found trazodone significantly improved subjective sleep quality and reduced sleep onset latency compared to placebo in insomnia patients, with generally mild adverse effects.
- 3Trazodone for erectile dysfunction: a systematic review and meta-analysisPMIDFink HA, MacDonald R, Rutks IR et al. · BJU international · 2003
Fink HA, MacDonald R, Rutks IR et al.. Trazodone for erectile dysfunction: a systematic review and meta-analysis. BJU international. 2003
Randomized controlled trials
3- 4Effect of viloxazine and trazodone in obstructive sleep apnoea: a randomised, placebo-controlled, cross-over studyPMIDAishah A, Kim M, Gell L et al. · Thorax · 2025
Aishah A, Kim M, Gell L et al.. Effect of viloxazine and trazodone in obstructive sleep apnoea: a randomised, placebo-controlled, cross-over study. Thorax. 2025
- 5Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trialPMIDPal S, Chataway J, Swingler R et al. · The Lancet. Neurology · 2024
Pal S, Chataway J, Swingler R et al.. Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial. The Lancet. Neurology. 2024
- 6A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST)PMIDEyob E, Shaw JS, Bakker A et al. · Journal of Alzheimer's disease : JAD · 2024
Eyob E, Shaw JS, Bakker A et al.. A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST). Journal of Alzheimer's disease : JAD. 2024
Reference material
5- 7Cipriani A et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018.Source linkedPMID
- 8Everitt H et al. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018.Source linkedPMID
- 9Wen S et al. Comparative gastrointestinal effects of antidepressants for the acute treatment of adults with major depressive disorder: a network and dose‒response meta-analysis. Transl Psychiatry. 2025.Source linkedPMID
- 10Kokkali M, Pinioti E, Lappas AS et al.. Effects of Trazodone on Sleep: A Systematic Review and Meta-analysis. CNS drugs. 2024Source linkedPMID
- 11Jaffer KY, Chang T, Vanle B et al.. Trazodone for Insomnia: A Systematic Review. Innovations in clinical neuroscience. 2017Source linkedPMID
Common questions.
Quick answers about Trazodone, drawn from the data on this page.
What is Trazodone?
Prescription serotonin antagonist and reuptake inhibitor (SARI) approved for major depressive disorder. Most commonly used off-label at low doses as a sleep aid due to its potent sedating and non-habit-forming properties. At higher antidepressant doses, provides serotonergic and anxiolytic activity. A widely used alternative to benzodiazepines and Z-drugs for insomnia. Dosage must be determined by your prescribing physician.
What is Trazodone used for?
Commonly cited benefits of Trazodone include: Insomnia improvement (off-label); Depression symptom relief; Anxiety reduction; Non-habit-forming sleep aid; No abuse potential. NutriStack rates the overall evidence as moderate.
What is a typical dose of Trazodone?
A typical adult dose of Trazodone is 50–100 mg at bedtime for insomnia; 150–400 mg daily for depression (as prescribed by your physician). The commonly recommended form is Tablet. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Trazodone?
Reported side effects include sedation and drowsiness, dizziness, orthostatic hypotension, dry mouth, headache, nausea. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Trazodone?
NutriStack rates this as Moderate, meaning several aligned RCTs or one large RCT plus supporting reviews. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Trazodone in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.